uPATCH

Vaccines should be easily accessible to every person on earth. uPRAX aims to make that happen by introducing microneedles to end-users. Their size of less than 1mm reduces pain and chances for infections, while simultaneously removing the need for in demand doctors and a costly distribution channel.

Development of our Adjustable Precision Applicator – the technology of which has been proven to have 95% penetration efficiency – was completed just before the Microneedles 2018 conference held in Vancouver, Canada. uPRAX Microsolutions attended and showed the applicator to experts in the field as well as making key connections.

The company is now trying to find a path to the end user by actively developing applicators that patients can use themselves. We envision versions of these products improving as researchers become more interested in reducing discrepancies in their research through the use of our custom designed applicators.

This space is very new and exciting as the potential for microneedles and the application of microneedles could be huge. Some researchers have over a decade of experience in this field and have proven there are many advantages over conventional drug administration and we want to be part of the movement that could revolutionize the medical industry.

Company’s Keywords:

design, sales, medical, microneedles, consultancy, networking